ArticleMedical oncology (Northwood, London, England)2019

Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.

Zumu Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.